{"id":20306,"date":"2022-10-03T09:23:13","date_gmt":"2022-10-03T13:23:13","guid":{"rendered":"https:\/\/medicarereport.org\/?p=20306"},"modified":"2022-10-03T10:39:12","modified_gmt":"2022-10-03T14:39:12","slug":"the-10-drugs-most-likely-to-be-the-1st-negotiated-by-medicare","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=20306","title":{"rendered":"The 10 drugs most likely to be the 1st negotiated by Medicare"},"content":{"rendered":"\n<p>(By Rylee Wilson for Becker&#8217;s Hospital Review on September 30, 2022)<\/p>\n\n\n\n<p>The first drugs negotiated by Medicare are likely to be blood thinners, diabetes treatments and cancer drugs, physicians\u00a0predicted in a Sept. 30 article for Health Affairs. <a href=\"https:\/\/www.beckerspayer.com\/payer\/the-10-drugs-most-likely-to-be-the-1st-negotiated-by-medicare.html\">here&#8230;<\/a>  <\/p>\n\n\n\n<p><\/p>\n\n\n\n<p> <img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"100\" class=\"wp-image-7795\" style=\"width: 150px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs.jpg 700w, https:\/\/medicarereport.org\/wp-content\/uploads\/2017\/08\/drugs-300x201.jpg 300w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rylee Wilson for Becker&#8217;s Hospital Review on September 30, 2022) The first drugs negotiated by Medicare are likely to<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18,12,6,15],"tags":[154,155],"class_list":["post-20306","post","type-post","status-publish","format-standard","hentry","category-aging","category-health-care-general","category-medicare-general","category-part-dprescription-drugs","tag-drugs","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20306","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=20306"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20306\/revisions"}],"predecessor-version":[{"id":20309,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/20306\/revisions\/20309"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=20306"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=20306"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=20306"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}